[go: up one dir, main page]
Scribd
Upload
255 views2 pages

Protocol Polyhydramnios

The document provides guidelines for screening and managing polyhydramnios, an excess of amniotic fluid complicating pregnancy. It defines polyhydramnios based on measurements of amniotic fluid pockets. Polyhydramnios is classified as mild, moderate, or severe. Major causes are diabetes, fetal anomalies, and in 50% of mild cases the cause is unknown. It increases risks of complications like macrosomia. Workup should include testing for glucose, infections, and a detailed ultrasound exam. Further testing is recommended for severe polyhydramnios or if anomalies are present.

Uploaded by

Fie Fie Adelaide
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
255 views2 pages

Protocol Polyhydramnios

The document provides guidelines for screening and managing polyhydramnios, an excess of amniotic fluid complicating pregnancy. It defines polyhydramnios based on measurements of amniotic fluid pockets. Polyhydramnios is classified as mild, moderate, or severe. Major causes are diabetes, fetal anomalies, and in 50% of mild cases the cause is unknown. It increases risks of complications like macrosomia. Workup should include testing for glucose, infections, and a detailed ultrasound exam. Further testing is recommended for severe polyhydramnios or if anomalies are present.

Uploaded by

Fie Fie Adelaide
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 2

Maternal Fetal Medicine

Polyhydramnios
Purpose: To provide guidelines for screening and management of polyhydramnios complicating pregnancy.

1. Definition: polyhydramnios is defined as a single deepest pocket (SDP) ≥8 cm at less than 24 weeks
or in a multiple gestation or amniotic fluid index (AFI) >25 cm (AFI ≥97.5 percentile) after 24 weeks.

2. Classification:
a. Mild polyhydramnios: AFI > 25 cm - 29.9 cm.
b. Moderate: AFI >30 cm – 34.9 cm.
c. Severe polyhydramnios: SDP ≥15 cm or AFI of ≥35 cm.

3. Etiology:
a. Major associations are diabetes and fetal malformation, but up to 50% of mild polyhydramnios
is of unknown cause (idiopathic).
b. Risk of major anomaly at birth after normal ultrasound is 1% with AFI <30, 2% with AFI 30 to
34.9, 11% with AFI ≥35 cm.

4. Implications for the pregnancy: Polyhydramnios is associated with higher rates of macrosomia,
malpresentation, cord prolapse, abruption, primary cesarean delivery, and uterine atony.

5. Workup should include (at least) a glucose screening test, antibody screen if not done in last four
weeks, RPR, and accurate fetal anatomy ultrasound. Parvovirus, toxoplasma, and CMV IgM and IgG
can be included. Amniocentesis should be strongly considered if there is severe polyhydramnios,
hydramnios with fetal anomaly on ultrasound, polyhydramnios associated with FGR or detected <24
weeks.

SHMG Maternal Fetal Medicine has developed these guidelines as a reference tool to assist referring physicians. Obstetric medical needs are complex
and these guidelines may not apply in every case. Treating clinicians should exercise their own professional medical judgment with regard to the
appropriate treatment and management of their patients. Treating clinicians are solely responsible for confirming the accuracy, timelines, completeness,
appropriateness and helpfulness of this material in making all medical, diagnostic, or prescription decisions.

Polyhydramnios | Updated 4 | pg. 1 www.spectrumhealth.org/for-health-professionals/for-providers/maternal-fetal-medicine


Maternal Fetal Medicine

SHMG Maternal Fetal Medicine has developed these guidelines as a reference tool to assist referring physicians. Obstetric medical needs are complex
and these guidelines may not apply in every case. Treating clinicians should exercise their own professional medical judgment with regard to the
appropriate treatment and management of their patients. Treating clinicians are solely responsible for confirming the accuracy, timelines, completeness,
appropriateness and helpfulness of this material in making all medical, diagnostic, or prescription decisions.

Polyhydramnios | Updated 4 | pg. 2 www.spectrumhealth.org/for-health-professionals/for-providers/maternal-fetal-medicine

You might also like